MPMarc A. Probst

Marc A. Probst

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Marc A. Probst has a total of 203 co-authors. Here are the top co-authors by number of shared publications:

  • Erik P. Hess

    Department of Emergency Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA

    6 shared publications
  • Benjamin C. Sun

    Department of Emergency Medicine, University of Pennsylvania, Philadelphia, PA

    5 shared publications
  • Alan B. Storrow

    Department of Emergency Medicine Vanderbilt University Medical Center Nashville Tennessee USA

    4 shared publications
  • Daniel K. Nishijima

    Department of Emergency Medicine UC Davis School of Medicine Sacramento California USA

    4 shared publications
  • Deborah B. Diercks

    Department of Emergency Medicine UT Southwestern Medical Center Dallas TX USA

    4 shared publications
  • Hemal K. Kanzaria

    Department of Emergency Medicine University of California at San Francisco, Zuckerberg San Francisco General Hospital San Francisco CA

    4 shared publications

Latest Publications

  • Diagnostic Yield of Hospitalization for Emergency Department Patients With Syncope and Presyncope

    by Christopher W. Baugh, Carolyn Winskill, Edward H. Suh, Dana L. Sacco, John DeAngelis, Daniel K. Nishijima, Jonathan Schimmel, Alan B. Storrow, Nancy Wood, Robert E. Weiss, et al.

    Objectives: Syncope and presyncope are common emergency department (ED) presentations that may indicate dangerous underlying conditions. For patients without serious ED diagnoses, hospitalization for monitoring and further workup is common, yet the benefits remain unclear. We sought to determine the diagnostic yield of hospitalization among adults with unexplained syncope or presyncope. Methods: We conducted a secondary analysis of data from a prospective, multicenter, observational study enrolling ED patients aged ≥ 40 years with syncope or presyncope and no serious ED diagnosis. We collected 30‐day serious adverse outcomes (SAOs), both cardiac and non‐cardiac, including only in‐hospital SAOs for admitted patients and all SAOs for discharged patients. Logistic and Cox regression analyses compared admitted and discharged participants using propensity score adjustment and matching. Results: Among 1263 patients (mean age 64.8 ± 13.1 years), 74 (5.9%) experienced any SAO, including 62 (4.9%) with serious cardiac outcomes. After propensity‐score adjustment, Bayesian logistic regression showed a significant difference in diagnostic yield (OR 3.70 [95% CrI 1.85–6.82]) in the hospitalized cohort. In a propensity‐score‐matched Cox regression analysis, hospitalization was associated with a shorter time to SAO diagnosis, with an HR of 12.43 (95% CI 2.94–52.48). Conclusion: Hospitalization increased the diagnostic yield for SAOs and accelerated time to diagnosis. It is reasonable to hospitalize select, higher‐risk adult patients over 40 years old with presyncope or syncope, even if no dangerous diagnosis is found in the ED. Trial Registration: ClinicalTrials.gov identifier: NCT04533425

  • Open Access

    Patient and Clinician Perceptions of a Deep Learning Model for Automated Screening for Patients At-Risk for Undiagnosed Structural Heart Disease in the Emergency Department: Cross-sectional Survey Study (Preprint)

    by Simon Jacob Peck, Joshua Tabuena, Youseff Jakher, Ali Abdelati, Amos Shemesh, Timothy Joseph Poterucha, Marc A. Probst, Pierre Elias, Rahul Sharma, Brock Daniels

    BACKGROUND EchoNext is a prospectively validated deep learning model that identifies patients at risk for underdiagnosed structural heart disease (SHD) from 12-lead electrocardiograms (ECGs) routinely acquired in the emergency department (ED). Successful translation of Artificial Intelligence (AI)-based clinical decision support tools from technical validation to clinical impact depends on stakeholder acceptance, yet few studies have assessed both patient and clinician perspectives on a specific AI tool embedded in a defined ED workflow. OBJECTIVE This study aimed to characterize ED patient and clinician perspectives on AI-enabled SHD screening using EchoNext, and to identify perceived facilitators and barriers to adoption prior to health system-wide deployment. METHODS Two structured cross-sectional surveys were administered to patients and clinicians at a single urban academic medical center. Patients aged 18-65 presenting with non-urgent ED complaints completed an in-person survey assessing AI familiarity, comfort with AI-assisted clinical tasks, and factors influencing acceptance. ED clinicians completed an electronic survey that included a standardized clinical vignette describing AI-ECG-generated best practice alert, and assessed trust, perceived utility, implementation concerns, and adoption priorities. Descriptive statistics were used to summarize responses. RESULTS Between July and October 2024, 102 patient surveys were completed (median age 34 years; 47% female; 49% white; 20% Asian; 20% Hispanic; 15% Black or African). While 56% reported knowing little to nothing about AI in healthcare, 72% were comfortable with AI identifying potential SHD, increasing to 94% when AI recommendations were further reviewed by a physician. Further, 84% expressed comfort with being contacted after their ED visit to schedule an ultrasound recommended by AI. Factors most strongly associated with acceptance included physician review (97%), sharing test results (95%), and model accuracy (93%) whereas disclosure of the use of AI was less influential (72%). Notably, 79% believed AI would make healthcare somewhat better or much better, though acceptance varied by age and race/ethnicity. Among 52 clinicians surveyed, 75% reported they would trust an AI-ECG tool’s recommendations. While 85% believed an AI-ECG tool would reduce missed SHD diagnoses, only 63% were confident it would improve outcomes. Accuracy and workflow integration ranked as the highest priorities for adoption; however, concerns regarding patient follow-up (95%) and medicolegal liability (86%) were common. CONCLUSIONS Acceptance of AI-enabled SHD screening was broadly favorable among both ED patients and clinicians but consistently conditional on physician oversight and implementation infrastructure. Patient concerns centered on trust and transparency, while clinician concerns centered on follow-up capacity and medicolegal accountability. This suggests that barriers to deployment are organizational frameworks rather than technical acceptance, and that sustainable integration of an AI-ECG tool requires structured follow-up pathways, liability frameworks, and targeted patient communication strategies, particularly for populations with lower baseline comfort and limited access to longitudinal care.

  • Predicting Echocardiography Findings in Adults Presenting to the Emergency Department With Syncope: An External Validation of the ROMEO Score

    by John DeAngelis, Gymar Vargas, Robert E. Weiss, Carolyn Winskill, Edward H. Suh, Dana L. Sacco, Nancy Wood, Daniel K. Nishijima, Alan B. Storrow, Jonathan Schimmel, et al.

    Background: Syncope is common in the Emergency Department (ED) and can be associated with structural heart disease (SHD). Transthoracic echocardiography (TTE) is commonly ordered to assess for SHD. Objective: To externally validate the previously developed ROMEO score, which identifies patients with syncope who are at very low risk of significant findings on TTE. Design: Secondary analysis of a multicenter, prospective, observational cohort study. Setting: One community and five academic EDs in the United States. Participants: Adults (≥ 40 years old) presenting to the ED with syncope or presyncope, without a serious ED diagnosis. Interventions: Receipt of TTE within 30 days of the index visit. Measurements: Our primary outcome was the rate of significant findings on TTE within 30 days of the index ED visit. We calculated the sensitivity, specificity, negative and positive predictive values (NPV, PPV), and the area under the curve (AUC) of the ROMEO score. Results: We enrolled 1287 patients, of whom 427 underwent TTE. 88 (20.6%) had a significant finding. A ROMEO score of zero had a sensitivity of 98.9% and a NPV of 98.6%. The specificity and PPV were 20.2% and 24.3%, respectively. The AUC was 0.83 (95% CI: 0.79 to 0.87). Limitations: Given the rate of non‐enrollment of screened patients, there is potential for selection bias. Our study sample was biased toward urban, academic centers; the results may not apply to community settings. Conclusions: The ROMEO score demonstrates strong predictive performance and may be useful to help clinicians identify patients who are unlikely to benefit from TTE. Trial Registration: ClinicalTrial.gov identifier: NCT04533425


  • A case of artificial intelligence-enhanced diagnostics leading to heart transplantation

    by Heidi S. Hartman, Joshua Finer, Dustin Hartzel, Christopher Kelsey, Aaron Long, Daniel Rocha, Jeffrey A. Ruhl, David Vanmaanen, Paloma P. Malta, Michelle Castillo, et al.


  • Open Access

    A Digital Patient Decision Aid to Increase Sexually Transmitted Infection Testing in the Emergency Department: Protocol for a Pilot Randomized Controlled Trial of the STIckER (STI Check in the Emergency Room) Study

    by Jason Zucker, Delivette Castor, Marc A Probst, Talia Adler, Lisa-Pierre Tchoungui, Jaciara De Souza, Christina Franqui, Lauren Chernick

    Background: Rising rates of sexually transmitted infections (STIs) among adolescents and young adults are concerning. Emergency department (ED) visits offer a unique opportunity to increase STI testing. However, providers in the ED may not have the time or self-efficacy to screen patients, and patients may be unable to initiate discussion on their STI care needs. A patient decision aid may improve the effectiveness and efficiency of the ED encounter for STI testing. Objective: This study aims to pilot STI Check in the Emergency Room (STIckER) app, a shared decision-making aid for urinary, oral, and rectal gonorrhea and chlamydia testing among adolescents and young adults, and assess STIckER’s efficacy and implementation outcomes in an adult and pediatric ED. Methods: We are conducting a parallel-group, two-arm provider-randomized controlled pilot trial in the adult and pediatric EDs at an urban academic medical center. Fifty providers were randomized 1:1 to intervention (trained on STIckER) or control (standard of care). Adolescents and young adults aged 14‐24 years, English-speaking, and sexually active within the past 6 months are recruited during eligible shifts and assigned to the study arm of their provider. The standard of care comparator consists of usual provider-initiated STI discussions and testing without access to the decision aid; control participants receive a QR code directing them to a simple landing page encouraging them to ask their provider about STI testing. The planned enrollment target was 44 providers and 140 adolescent and young adult participants. Primary outcome is preliminary efficacy, defined as the proportion of adolescents and young adults receiving gonorrhea and chlamydia testing based on electronic medical record (EMR) review. Secondary outcomes include extragenital testing uptake, STI positivity rates, decisional conflict, and perceived level of shared decision-making. Implementation outcomes include feasibility, acceptability, appropriateness (using acceptability of intervention measure, intervention appropriateness measure, and feasibility of intervention measure), and provider self-efficacy. Data will be analyzed using descriptive statistics and regression models, with mixed-effects models applied if clustering by provider is detected. Exploratory analyses will examine differences by patient age, gender, and sexual identity, and provider characteristics. Results: Between September 2023 and July 2025, we completed recruitment of 44 providers and 139 adolescent and young adult participants across both adult and pediatric EDs. Enrollment targets were met, with high fidelity to intervention delivery and strong rates of survey completion by both patients and providers. Final data cleaning and analyses are underway, and primary results are expected to be available in late 2025. Conclusions: This pilot trial will provide critical data on the feasibility, acceptability, and preliminary efficacy of a digital SDM tool to increase STI testing in the ED. Findings will inform the design of a future multisite trial and the potential for scaling STIckER to support equitable, patient-centered STI screening across diverse clinical settings.


  • Top Cited Papers
    Open Access

    Detecting structural heart disease from electrocardiograms using AI

    by Timothy J. Poterucha, Linyuan Jing, Ramon Pimentel Ricart, Michael Adjei-Mosi, Joshua Finer, Dustin Hartzel, Christopher Kelsey, Aaron Long, Daniel Rocha, Jeffrey A. Ruhl, et al.

    Early detection of structural heart disease is critical to improving outcomes, but widespread screening remains limited by the cost and accessibility of imaging tools such as echocardiography1,2. Recent advances in machine learning applied to heart rhythm recordings have shown promise in identifying disease3,4, although previous work has been limited by development in narrow populations or targeting only select heart conditions5. Here we introduce a deep learning model, EchoNext, trained on more than 1 million heart rhythm and imaging records across a large and diverse health system to detect many forms of structural heart disease. The model demonstrated high diagnostic accuracy in internal and external validation, outperforming cardiologists in a controlled evaluation and showing consistent performance across different care settings and racial and/or ethnic groups. The models were prospectively evaluated in a clinical trial of patients without previous cardiac imaging, successfully identifying previously undiagnosed heart disease. These findings support the potential of artificial intelligence to expand access to heart disease screening at scale. To enable further development and transparency, we have publicly released model weights and a large, annotated dataset linking heart rhythm data to imaging-based diagnoses.


  • Development of a Novel Emergency Department Quality Measure to Reduce Very Low-Risk Syncope Hospitalizations

    by Marc A. Probst, Alexander T. Janke, Adrian D. Haimovich, Arjun K. Venkatesh, Michelle P. Lin, Keith E. Kocher, Marie-Joe Nemnom, Venkatesh Thiruganasambandamoorthy


  • Open Access

    Clinicians' perspectives on the implementation of patient decision aids in the emergency department: A qualitative interview study

    by Tausif Billah, Lauren Gordon, Elizabeth M. Schoenfeld, Bernard P. Chang, Erik P. Hess, Marc A. Probst


  • Open Access

    Guidelines for reasonable and appropriate care in the emergency department (GRACE): Recurrent, low‐risk chest pain in the emergency department

    by Paul I. Musey, Fernanda Bellolio, Suneel Upadhye, Anna Marie Chang, Deborah B. Diercks, Michael Gottlieb, Erik P. Hess, Michael C. Kontos, Bryn E. Mumma, Marc A. Probst, et al.

    This first Guideline for Reasonable and Appropriate Care in the Emergency Department (GRACE‐1) from the Society for Academic Emergency Medicine is on the topic: Recurrent, Low‐risk Chest Pain in the Emergency Department. The multidisciplinary guideline panel used The Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach to assess the certainty of evidence and strength of recommendations regarding eight priority questions for adult patients with recurrent, low‐risk chest pain and have derived the following evidence based recommendations: (1) for those >3 h chest pain duration we suggest a single, high‐sensitivity troponin below a validated threshold to reasonably exclude acute coronary syndrome (ACS) within 30 days; (2) for those with a normal stress test within the previous 12 months, we do not recommend repeat routine stress testing as a means to decrease rates of major adverse cardiac events at 30 days; (3) insufficient evidence to recommend hospitalization (either standard inpatient admission or observation stay) versus discharge as a strategy to mitigate major adverse cardiac events within 30 days; (4) for those with non‐obstructive (<50% stenosis) coronary artery disease (CAD) on prior angiography within 5 years, we suggest referral for expedited outpatient testing as warranted rather than admission for inpatient evaluation; (5) for those with no occlusive CAD (0% stenosis) on prior angiography within 5 years, we recommend referral for expedited outpatient testing as warranted rather than admission for inpatient evaluation; (6) for those with a prior coronary computed tomographic angiography within the past 2 years with no coronary stenosis, we suggest no further diagnostic testing other than a single, normal high‐sensitivity troponin below a validated threshold to exclude ACS within that 2 year time frame; (7) we suggest the use of depression and anxiety screening tools as these might have an effect on healthcare use and return emergency department (ED) visits; and (8) we suggest referral for anxiety or depression management, as this might have an impact on healthcare use and return ED visits.